Literature DB >> 17608827

Prognostic impact of carbonic anhydrase IX expression in human renal cell carcinoma.

Johanna Sandlund1, Egbert Oosterwijk, Kjell Grankvist, Jeannette Oosterwijk-Wakka, Börje Ljungberg, Torgny Rasmuson.   

Abstract

OBJECTIVE: To evaluate the prognostic information of carbonic anhydrase (CA) IX expression in patients with renal cell carcinoma (RCC), as increased expression of CA IX is correlated with a worse prognosis in several malignancies. PATIENTS AND METHODS: CA IX expression was assessed in RCC tumours from 228 patients, using a tissue microarray technique on archival material. The expression was related to RCC cell type, Tumour-Node-Metastasis (TNM) stage, nuclear grade and survival.
RESULTS: CA IX expression was significantly higher (P < 0.001) in 183 conventional than in 31 papillary RCC and 14 chromophobe RCC. For conventional RCC there was no correlation of CA IX expression with TNM stage or nuclear grade. To evaluate the prognostic information conventional RCC tumours were subdivided arbitrarily into three groups according to the CA IX expression, of 0-10%, 11-90% and 91-100% expression, respectively. Patients with tumours with 0-10% expression had a less favourable prognosis than those with 11-90% and 91-100% expression (P = 0.012, and 0.001), respectively. A multivariate analysis of prognostic factors for patients with conventional RCC showed that TNM stage, nuclear grade and CA IX were independent predictors of prognosis.
CONCLUSION: These results show that CA IX expression is higher in conventional than other RCC cell types; furthermore, patients with conventional RCC with low CA IX expression had a less favourable prognosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17608827     DOI: 10.1111/j.1464-410X.2007.07006.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  25 in total

Review 1.  Molecular marker for predicting treatment response in advanced renal cell carcinoma: does the promise fulfill clinical need?

Authors:  Michael Garcia-Roig; Nicolas Ortiz; Vinata Lokeshwar
Journal:  Curr Urol Rep       Date:  2014-01       Impact factor: 3.092

2.  Value of metastin receptor immunohistochemistry in predicting metastasis after radical nephrectomy for pT1 clear cell renal cell carcinoma.

Authors:  Sunao Shoji; Mayura Nakano; Tetsuro Tomonaga; Hakushi Kim; Kazuya Hanai; Yukio Usui; Yoshihiro Nagata; Masaki Miyazawa; Haruhiro Sato; Xian Yang Tang; Yoshiyuki Robert Osamura; Toyoaki Uchida; Toshiro Terachi; Koichi Takeya
Journal:  Clin Exp Metastasis       Date:  2013-01-01       Impact factor: 5.150

Review 3.  The current status of tailor-made medicine with molecular biomarkers for patients with clear cell renal cell carcinoma.

Authors:  Sunao Shoji; Mayura Nakano; Haruhiro Sato; Xian Yang Tang; Yoshiyuki Robert Osamura; Toshiro Terachi; Toyoaki Uchida; Koichi Takeya
Journal:  Clin Exp Metastasis       Date:  2014-01       Impact factor: 5.150

Review 4.  Prognostic and predictive biomarkers in renal cell carcinoma.

Authors:  Michael M Vickers; Daniel Y C Heng
Journal:  Target Oncol       Date:  2010-06-28       Impact factor: 4.493

Review 5.  State of the science: an update on renal cell carcinoma.

Authors:  Eric Jonasch; P Andrew Futreal; Ian J Davis; Sean T Bailey; William Y Kim; James Brugarolas; Amato J Giaccia; Ghada Kurban; Armin Pause; Judith Frydman; Amado J Zurita; Brian I Rini; Pam Sharma; Michael B Atkins; Cheryl L Walker; W Kimryn Rathmell
Journal:  Mol Cancer Res       Date:  2012-05-25       Impact factor: 5.852

6.  Generation of a mouse model of Von Hippel-Lindau kidney disease leading to renal cancers by expression of a constitutively active mutant of HIF1α.

Authors:  Leiping Fu; Gang Wang; Maria M Shevchuk; David M Nanus; Lorraine J Gudas
Journal:  Cancer Res       Date:  2011-09-09       Impact factor: 12.701

7.  Carbonic anhydrase IX has chaperone-like functions and is an immunoadjuvant.

Authors:  Yanping Wang; Xiang-Yang Wang; John R Subjeck; Hyung L Kim
Journal:  Mol Cancer Ther       Date:  2008-12       Impact factor: 6.261

8.  Carbonic anhydrase IX is a clinically significant tissue and serum biomarker associated with renal cell carcinoma.

Authors:  Martina Takacova; Maria Bartosova; Lucia Skvarkova; Miriam Zatovicova; Ivana Vidlickova; Lucia Csaderova; Monika Barathova; Jan Breza; Peter Bujdak; Jaromir Pastorek; Jan Breza; Silvia Pastorekova
Journal:  Oncol Lett       Date:  2012-10-26       Impact factor: 2.967

9.  Vimentin over-expression and carbonic anhydrase IX under-expression are independent predictors of recurrence, specific and overall survival in non-metastatic clear-cell renal carcinoma: a validation study.

Authors:  A Ingels; M Hew; F Algaba; O J de Boer; R J A van Moorselaar; S Horenblas; P Zondervan; J J M C H de la Rosette; M Pilar Laguna Pes
Journal:  World J Urol       Date:  2016-05-20       Impact factor: 4.226

10.  Expression of the anti-inflammatory suppressor of cytokine signaling 3 (SOCS3) in human clear cell renal cell carcinoma.

Authors:  Anja Urbschat; Svenja Stumpf; Jörg Hänze; Patrick Paulus; Thorsten J Maier; Christine Weipert; Rainer Hofmann; Axel Hegele
Journal:  Tumour Biol       Date:  2016-01-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.